marimastat has been researched along with rtki cpd in 1 studies
Studies (marimastat) | Trials (marimastat) | Recent Studies (post-2010) (marimastat) | Studies (rtki cpd) | Trials (rtki cpd) | Recent Studies (post-2010) (rtki cpd) |
---|---|---|---|---|---|
215 | 28 | 53 | 744 | 0 | 257 |
Protein | Taxonomy | marimastat (IC50) | rtki cpd (IC50) |
---|---|---|---|
Epidermal growth factor receptor | Homo sapiens (human) | 0.0584 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Harder, J; Mildner, M; Rademacher, F; Schröder, L; Simanski, M | 1 |
1 other study(ies) available for marimastat and rtki cpd
Article | Year |
---|---|
The role of RNase 7 in innate cutaneous defense against Pseudomonas aeruginosa.
Topics: ADAM17 Protein; Antibodies, Neutralizing; Cells, Cultured; Cetuximab; Epidermis; ErbB Receptors; Gene Expression; Gene Silencing; Humans; Hydroxamic Acids; Keratinocytes; Organoids; Pseudomonas aeruginosa; Quinazolines; Ribonucleases; RNA, Small Interfering; Signal Transduction; Skin; Toll-Like Receptor 5; Tyrphostins | 2017 |